Thor Alvegård
1 – 50 of 50
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Survival Outcomes Associated with 3 Years vs 1 Year of Adjuvant Imatinib for Patients with High-Risk Gastrointestinal Stromal Tumors : An Analysis of a Randomized Clinical Trial after 10-Year Follow-up
(
- Contribution to journal › Article
- 2017
-
Mark
The Scandinavian Sarcoma Group Central Register : 6,000 patients after 25 years of monitoring of referral and treatment of extremity and trunk wall soft-tissue sarcoma
(
- Contribution to journal › Article
- 2016
-
Mark
Adjuvant Imatinib for High-Risk GI Stromal Tumor: Analysis of a Randomized Trial.
(
- Contribution to journal › Article
-
Mark
Needle biopsy through the abdominal wall for the diagnosis of gastrointestinal stromal tumour - Does it increase the risk for tumour cell seeding and recurrence?
(
- Contribution to journal › Article
- 2014
-
Mark
Oral contraceptive use, parity, and constitutional characteristics in soft tissue sarcoma: a Swedish population-based case-control study 1988-2009.
(
- Contribution to journal › Article
- 2012
-
Mark
One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor : A Randomized Trial
(
- Contribution to journal › Article
- 2011
-
Mark
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol
(
- Contribution to journal › Article
-
Mark
Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma 63 patients with a minimum follow-up of 4 years
(
- Contribution to journal › Article
- 2009
-
Mark
The Scandinavian Sarcoma Group Summary of the first 30 years
(
- Contribution to journal › Article
-
Mark
Scandinavian experience in classical osteosarcoma Results of the SSG XIV protocol
(
- Contribution to journal › Article
-
Mark
The European postmarketing adult Osteosarcoma Surveillance Study: characteristics of patients A preliminary report
(
- Contribution to journal › Article
-
Mark
Treatment of localized Ewing sarcoma family of tumors The Scandinavian Sarcoma Group experience
(
- Contribution to journal › Article
-
Mark
The Scandinavian Sarcoma Group Register 1986-2008
(
- Contribution to journal › Article
-
Mark
Translocation-related sarcomas.
(
- Contribution to journal › Article
- 2008
-
Mark
Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
(
- Contribution to journal › Article
- 2006
-
Mark
May P-glycoprotein status be used to stratify high-grade osteosarcoma patients? Results from the Italian/Scandinavian Sarcoma Group 1 treatment protocol
(
- Contribution to journal › Article
- 2005
-
Mark
Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: A joint study by the Italian and Scandinavian Sarcoma Groups
(
- Contribution to journal › Article
-
Mark
The influence of surgical volume on hospital mortality and 5-year survival for carcinoma of the oesophagus and gastric cardia.
(
- Contribution to journal › Article
-
Mark
Improved prognostication in soft tissue sarcoma: independent information from vascular invasion, necrosis, growth pattern, and immunostaining using whole-tumor sections and tissue microarrays.
(
- Contribution to journal › Article
-
Mark
The cost-effectiveness of post-operative radiotherapy after breast conservation surgery in stage I-II breast cancer in Sweden
(
- Contribution to journal › Published meeting abstract
- 2004
-
Mark
Time dependence of prognostic factors for patients with soft tissue sarcoma : a Scandinavian Sarcoma Group Study of 338 malignant fibrous histiocytomas
(
- Contribution to journal › Article
-
Mark
The Scandinavian Sarcoma Group--background, organization and the SSG Register--the first 25 years
(
- Contribution to journal › Article
-
Mark
Hospital stay related to TNM-stage and the surgical procedure in primary breast cancer
(
- Contribution to journal › Article
-
Mark
Expression profiling using tissue microarray in 211 malignant fibrous histiocytomas confirms the prognostic value of Ki-67.
(
- Contribution to journal › Article
-
Mark
Chemotherapy in Ewing's sarcoma: The Scandinavian Sarcoma Group experience
(
- Contribution to journal › Article
-
Mark
The Scandinavian Sarcoma Group Register 1986-2001
(
- Contribution to journal › Article
-
Mark
Chemotherapy in osteosarcoma: The Scandinavian Sarcoma Group experience
(
- Contribution to journal › Article
- 2003
-
Mark
Scandinavian Sarcoma Group Osteosarcoma Study SSG VIII: prognostic factors for outcome and the role of replacement salvage chemotherapy for poor histological responders
(
- Contribution to journal › Article
-
Mark
Prognostic information in soft tissue sarcoma using tumour size, vascular invasion and microscopic tumour necrosis-the SIN-system.
(
- Contribution to journal › Article
-
Mark
The cost of treating pancreatic cancer--a cohort study based on patients' records from four hospitals in Sweden.
(
- Contribution to journal › Article
-
Mark
Prostate cancer - Prevalence-based healthcare costs
(
- Contribution to journal › Article
- 2001
-
Mark
Tissue microarray technique in soft tissue sarcoma: immunohistochemical Ki-67 expression in malignant fibrous histiocytoma
(
- Contribution to journal › Article
-
Mark
Computed tomography of pulmonary metastases from osteosarcoma: The less poor technique. A study of 51 patients with histological correlation
(
- Contribution to journal › Article
-
Mark
Monitoring referral and treatment in soft tissue sarcoma: study based on 1,851 patients from the Scandinavian Sarcoma Group Register
(
- Contribution to journal › Article
- 2000
-
Mark
Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol
(
- Contribution to journal › Article
- 1999
-
Mark
Chemotherapy in Ewing's sarcoma. The Scandinavian Sarcoma Group experience
(
- Contribution to journal › Article
-
Mark
Chemotherapy in osteosarcoma. The Scandinavian Sarcoma Group experience
(
- Contribution to journal › Article
-
Mark
Clinical course in synovial sarcoma : A Scandinavian sarcoma group study of 104 patients
(
- Contribution to journal › Article
- 1997
-
Mark
Chemotherapy for osteosarcoma and Ewing's sarcoma
(
- Contribution to journal › Article
-
Mark
Prognostic factors in bone sarcomas
(
- Contribution to journal › Article
- 1996
-
Mark
Urokinase-plasminogen-activator levels and prognosis in 69 soft-tissue sarcomas
(
- Contribution to journal › Article
- 1995
-
Mark
The Sarcoma Group
(
- Contribution to journal › Article
-
Mark
Expression of proliferating cell nuclear antigen (PCNA) and Ki‐67 in soft tissue sarcoma. Is prognostic significance histotype‐specific?
(
- Contribution to journal › Scientific review
- 1994
-
Mark
Prognostic value of Ki-67 expression in 182 soft tissue sarcomas. Proliferation--a marker of metastasis?
(
- Contribution to journal › Article
- 1991
-
Mark
Malignant fibrous histiocytoma of soft tissue - A population-based epidemiologic and prognostic study of 137 patients
1991) p.67-67(
- Contribution to conference › Paper, not in proceeding
-
Mark
Malignant fibrous histiocytoma of soft tissue. A population‐based epidemiologic and prognostic study of 137 patients
(
- Contribution to journal › Article
-
Mark
Limb-sparing surgery without radiotherapy based on anatomic location of soft tissue sarcoma
(
- Contribution to journal › Article
- 1990
-
Mark
Cellular DNA content and prognosis of high-grade soft tissue sarcoma: the Scandinavian Sarcoma Group experience
(
- Contribution to journal › Article
-
Mark
Calculation and measurements of absorbed dose in total body irradiation
(
- Contribution to journal › Article
-
Mark
Management and prognosis of patients with high-grade soft tissue sarcomas An evaluationof a Scandinavian joint care program
(
- Contribution to journal › Article